Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial
安罗替尼联合苯麦司托巴作为晚期食管鳞状细胞癌的一线无化疗治疗方案：一项探索性多中心单臂II期临床试验
期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-025-02376-w
Meng, Xiangrui; Yang, Xiuli; Hong, Yonggui; Wang, Wenkang; Zhang, Zhiye; Xia, Jin; Chen, Yunfang; Zhou, Yue; Lu, Taiying; Song, Min; Shan, Zhengzheng; Wu, Tao; Wu, Weilong; Shen, Ling; Guan, Lulu; Ma, Mingying; Wang, Lisen; Luo, Xi; Xin, Dao; Ma, Yihui; Jiang, Guozhong; Qi, Yu; Jiang, Binghua; Zhang, Daoyu; Hu, Biao; Wu, Xiaoying; Peng, Zuofu; Wang, Feng
